Abstract
An endoscopic manometric technique was used to investigate the effects of glucagon on pancreatic duct, common bile duct, pancreatic duct sphincter, and bile duct sphincter pressures in 20 healthy volunteers. Glucagon was given by intravenous infusion at rates of 0.016, 0.0625, 0.25, 1.0, 4.0, and 16.0 μg/kg/hr and also as an intravenous bolus of 1 mg. Plasma glucagon was measured by radioimmunoassay. Glucagon significantly reduced peak bile duct sphincter pressure from 49.1±3.7 mm Hg (mean±sd) to 37.8±2.9 mm Hg (P<0.01) at a rate of 0.016 μg/kg/hr, reaching a maximum effect at rates of 0.25 μg/kg/hr and above. Reduction in pancreatic duct sphincter, pancreatic duct, and bile duct pressures; slowing of sphincter wave frequency; and shortening of wave duration occurred at infusion rates of 1.0 μg/kg/hr or greater when plasma concentrations were supraphysiological. We conclude that glucagon has a physiological action on the bile duct sphincter but that all other effects on this area are pharmacological.
Similar content being viewed by others
References
Cotton PB: Progress report: ERCP. Gut 18:316–341, 1977
Lin T-M: Actions of gastrointestinal hormones and related peptodes on the motor function of the biliary tract. Gastroenterology 69:1006–1022, 1975
Rey J-F, Harvey RF: Hormonal control of the sphincter of Oddi.In The Sphincter of Oddi, Proceedings of the 3rd Gastroenterology Symposium, Nice, 1976, Basel, Karger, 1977, pp 66–71
Shaffer RD, Hogan WJ, Geenen JE, Dodds WJ, Stewart ET, Arndofer RC: Sphincter of Oddi motor activity: Demonstration of unique high pressure phasic contractions Gastroenterology 72:A107/1130, 1977
Nebel OT: Effect of enteric hormones on the human sphincter of Oddi. Gastroenterology 68:A105/962, 1975
Carr-Locke DL, Gregg JA: Endoscopic manometry of pancreatic and biliary sphincters zones in man: Basal results in healthy volunteers. Dig Dis Sci 26:7–15, 1981
Sherwin R, Felig P: Glucagon physiology in health and disease.In Endocrine Physiology 2, International Review of Physiology. SM McCann (ed). Baltimore, University Park Press, 1977, pp 151–171
Cain JE, Barbezat GO, Waterworth MM, Bank S: Glucagon inhibition of secretin and combined secretin and cholecystokinin stimulated pancreatic exocrine secretion in health and disease. Digestion 17:11–17, 1978
Loud FB, Froberg D, Reichardt J, Holst JJ, Rehfeld JF, Christiansen J: Inhibition of meal-stimulated gastric acid secretion in man by exogenous and endogenous pancreatic glucagon. Scand J Gastroenterol 13:795–798, 1978
Weir GC, Turner RC, Martin DB: Glucagon radioimmunoassay using antiserum 30K: Interference by plasma. Horm Metab Res 5:241–244, 1973
Unger RH, Aguilar-Parada E, Muller WA, Eisentrant AM: Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest 49:837–848, 1970
Ganda OP, Aoki TT, Soeldner JS, Morrison RS, Cahill GF Jr: Hormone-fuel concentrations in anephric subjects. J Clin Invest 57:1403–1411, 1976
Andersson K-E, Andersson R, Hedner P, Persson CGA: Effect of cholecystokinin on the level of cyclic AMP and mechanical activity in the isolated sphincter of Oddi. Life Sci 11:723–732, 1972
Carr-Locke DL, Gregg JA, Chey WY: Effect of exogenous secretin on pancreatic and biliary ductal and sphincteric pressures in man demonstrated by endoscopic manometry and correlation with plasma secretin levels. Am J Gastroenterol 72:333, 1979
Author information
Authors and Affiliations
Additional information
This work was supported by grants from the Katherine Gavriluk and Sara Jordan Funds, New England Baptist Hospital, Boston, Massachusetts, NIH AM-15191, RR 05673; Dr. Carr-Locke is also in receipt of grants from the Wellcome Research Travel Fund, London, England, the Leicester Area Health Authority, Leicester, England, and the P&C Hickinbotham Trust, Leicester, England.
Rights and permissions
About this article
Cite this article
Carr-Locke, D.L., Gregg, J.A. & Aoki, T.T. Effects of exogenous glucagon on pancreatic and biliary ductal and sphincteric pressures in man demonstrated by endoscopic manometry and correlation with plasma glucagon. Digest Dis Sci 28, 312–320 (1983). https://doi.org/10.1007/BF01324947
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01324947